
    
      study aim is to tailor the therapy in order to administer the lowest cumulative dose of
      therapy yet considered safe in order to reduce both early and late therapy related
      complications.

      patients will be divided according to risk factors to sub groups of early favorable, early
      unfavorable, advanced disease with score less then 3 points or higher then 3 points.

      Early Interim PET will be carried out Further therapy will be based on the study results.
    
  